XML 40 R28.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Reporting (Tables)
 9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
Segment Expenses

As a single reportable segment entity, the Company’s segment performance measure is net income / (loss) attributable to shareholders. Significant segment expenses, as provided to the CODM, are presented below:

   
Three Months Ended
September 30,
    
Nine Months Ended
September 30,
  
   
2025
    
2024
     2025     2024  
Segment expenses
                        
Salaries and Benefits
  
$
3,656,376
    
$
4,167,471
     $ 10,343,215    
$
12,474,891
  
Professional fees
    
1,465,862
      
876,145
       3,871,489       3,641,823  
General administrative expenses
    
361,546
      
351,081
       1,093,797       1,094,648  
Clinical development expenses
    
1,898,406
      
2,153,068
       3,213,001       5,477,838  
Other development expenses
    
757,952
      
2,630,929
       6,347,749       6,271,425  
Total operating and segment expenses
  
$
8,140,142
     $ 10,178,694
    $ 24,869,251
    $ 28,960,625  
                                 
Interest income
    
281,109
      
666,770
       992,582       2,010,874  
Interest expense
    
(1,150,378
)
    
(1,214,734
)
     (4,225,737 )     (3,577,450 )
Benefit from income taxes
    
-
      
-
       1,169,820       869,169  
Segment and consolidated net loss
  
$
(9,009,411
)
  
$
(10,726,658
)
   $ (26,932,586 )   $ (29,658,032 )